Skip to main content
Skip to section navigation
Skip to footer
Home
About Us
Overview
Management Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Our Science
Product Pipeline
Overview
PMN310 | Amyloid-Beta
PMN267 | TDP-43
PMN442 | Alpha-Synuclein
Vaccines
Posters & Publications
Clinical Trials
Investors
Overview
News & Events
Company Info
Financial Results
Stock Data
SEDAR
SEC Filings
Governance
Contact
In The News
News & Media
News & Media
Press Releases
Events
In The News
Videos
Commentary
Podcasts
Aug 2, 2017
BRIEF-Promis Neurosciences increases size of private placement to $6 mln
Jul 31, 2017
‘Ninja drug’ prevents Alzheimer’s by destroying harmful cells in the brain
Jul 18, 2017
Biotech with Alzheimer's Focus Makes Progress on Several Fronts
Jul 17, 2017
Alzheimer's drug developers still hoping for a homer
May 9, 2017
BRIEF-Promis Neurosciences reports q1 2017 annual results
May 3, 2017
The ProMIS of an Alzheimer's Cure
rss_feed
RSS
arrow_back
1
2
3
4
5
6